Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Immunohorizons|January 13, 2023
Augmenting Granzyme B-Expressing NK Cells by Invariant NKT Ligand-Loaded APCs in Patients with Postoperative Early Stage Non-Small Cell Lung Cancer: Results of a Randomized Phase II StudyTomonori Iyoda, Kanako Shimizu, Masami Kawamura, et al.
In Vivo (Athens, Greece)|June 30, 2026
Nutritional Support for Treatment Continuity and Survival in Advanced Gastric Cancer: A Propensity Score-matched StudyKeiji Sugiyama, Takumi Ito, Masahiro Yaguchi, et al.
Trials|September 17, 2017
A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trialHideo Saka, Chiyoe Kitagawa, Yukito Ichinose, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 9, 2024
J-AVENUE: A retrospective, real-world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first-line maintenance therapy in JapanEiji Kikuchi, Nozomi Hayakawa, Masashi Nakayama, et al.
JAMA Network Open|August 15, 2025
Electronic Patient-Reported Outcomes With Vital Sign Monitoring During Trastuzumab Deruxtecan Therapy: The PRO-DUCE Randomized Clinical TrialYuichiro Kikawa, Yukari Uemura, Tetsuhiko Taira, et al.
Scientific Reports|November 13, 2023
Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancerTakeshi Masuda, Satoru Miura, Yuki Sato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2026
Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met-Targeting Antibody-Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction CancerJohn H Strickler, Judith Raimbourg, Jonathan E Cohen, et al.
BMC Cancer|April 12, 2025
A phase I/II trial evaluating the safety of increased-dose S- 1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancerKeisuke Baba, Nobumi Suzuki, Chiyo K Imamura, et al.
Pageof 7